Description
Retatrutide is a synthetic triple-agonist research peptide analog of GIP, GLP-1, and glucagon. It is supplied as a high-purity lyophilized powder for laboratory use only.
The compound is a modified incretin-related peptide with a fatty-acid side chain. Reported specifications commonly include a molecular weight of approximately 4731 g/mol. Identity and purity are confirmed by HPLC and mass spectrometry.
In laboratory and preclinical research, retatrutide has been investigated for effects on GIP, GLP-1, and glucagon receptor signaling, including studies related to incretin-pathway activity, energy-balance models, and metabolic-regulation mechanisms in experimental systems. These findings are limited to research settings and do not establish approved medical use.
This material is not approved for human or veterinary use and is not intended for consumption.
Reviews
There are no reviews yet.